SLC38A2 and type 2 diabetes mellitus: SNAT2 is also involved in transport of alanine into hepatocytes as precursors of gluconeogenesis and may have thus potential to reduce fasting blood glucose levels in type 2 diabetes (Velazquez-Villegas et al., 2021).